Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will webcast its
Annual Meeting of Shareholders live at 4 p.m. (PT), on June 17, 2009.
Following the formal business of the meeting, Affymetrix President and
Chief Executive Officer Kevin King will provide an update on the company
and its accomplishments in fiscal year 2008.
A live webcast of the presentation will be available at http://www.affymetrix.com
under the "Investors" link in the "About Affymetrix" drop-down menu.
Please log in ten minutes prior to register for the webcast and check
your system for the appropriate webcast software. Archived webcasts will
be available for 30 days
About Affymetrix
Affymetrix GeneChip® microarray technology is the
industry-standard tool for analyzing complex genetic information. After
inventing microarray technology in the late 1980s, Affymetrix scientists
have been dedicated to developing innovative products that provide
researchers with a more complete view of the genome. These products
continue to accelerate genetic research. They enable scientists to
develop diagnostics which may support the tailoring of treatments for
patients by identifying and measuring the genetic information associated
with complex diseases.
Today, Affymetrix technology is used by the world’s top pharmaceutical,
diagnostic and biotechnology companies, as well as leading academic,
government and not-for-profit research institutes. More than 1,800
systems have been shipped around the world and more than 18,000
peer-reviewed papers have been published using the technology.
Affymetrix is headquartered in Santa Clara, Calif., and has
manufacturing facilities in Cleveland, Ohio, and Singapore. The company
has about 1,100 employees worldwide and maintains sales and distribution
operations across Europe and Asia. For more information about
Affymetrix, please visit the company’s website at www.affymetrix.com.
NOTE: Affymetrix, the Affymetrix logo and GeneChip(R) are registered
trademarks owned or used by Affymetrix Inc.
Affymetrix, Inc.
Doug Farrell, 408-731-5285
Vice President,
Investor Relations
